From today, we’re bringing together our family of agencies under the AMICULUM® brand. This integration of our teams maximizes the breadth of specialities that we can offer to all our clients and gives us even greater agility to respond to client needs in the ever-changing healthcare landscape. See this press release for more information: https://loom.ly/iohz4Pg
About us
Activating science: Science underpins everything we do at AMICULUM. We use our diverse experience to create compelling insights-based narratives and experiences that bring our clients’ data and brands to life for audiences from HCPs through to payers and patients. Transforming health: Working in collaboration with our clients and the global medical community, our mission is to bring medical innovations to patients to enable the transformation of health. AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing needs of healthcare audiences we’re able to take an insights-driven, and technology-enabled, omnichannel approach that provides precision engagement for our clients. This results in optimized individual experiences for audiences spanning HCPs, payers, patients and advocates. We have expertise in many specialist areas, including teams focused on rare diseases and cell and gene therapies. We work with client teams across functions and at both Global and regional levels, including presence in the pan-Asia market. To find out more about AMICULUM get in touch at [email protected].
- Website
-
http://www.amiculum.biz
External link for AMICULUM
- Industry
- Business Consulting and Services
- Company size
- 201-500 employees
- Headquarters
- Bollington, Cheshire
- Type
- Privately Held
- Founded
- 2001
- Specialties
- Healthcare communications, Digital engagement, Rare diseases and uncommon cancers, Medical affairs, Commercial and clinical consulting, Medical writing, Meetings and events (live and virtual), Market access/HEOR, Advocacy, Healthcare learning and training, Genetically informed healthcare, Clinical development, Publications, Payer communications, and Opportunity assessment
Locations
-
Primary
The Boathouse
Clarence Mill
Bollington, Cheshire SK10 5JZ, GB
Employees at AMICULUM
Updates
-
Developing a product to prevent or treat a rare disease involves unique challenges from hard-to-identify and dispersed patient populations for clinical trials through to undefined endpoints and regulatory requirements. While each condition individually has a small population there are over 30 million people affected by rare diseases in the US alone. It’s therefore encouraging to read today that the FDA is establishing a Rare Disease Innovation Hub to connect with the rare disease patient and caregiver community, to enhance collaboration across FDA centres and to advance regulatory science. We look forward to seeing how this new initiative can accelerate treatment and prevention options across rare disease populations #raredisease #fda #patientcentricity
-
Can AI truly tell original stories? This was a hot topic at the ISMPP Annual Meeting and highlights the broader changes sweeping through the publications industry. As we reach the halfway point of the year, our latest blog post reflects on the key publications trends in 2024 so far, from generative AI to storytelling and patient inclusion. Read the full blog by Teal Brechtel, PhD and Jennifer Gillman for insights into these trends and more! https://loom.ly/pOmuMNE #MedicalPublications #AI #PatientInclusion #Storytelling #ISMPP2024
-
Next week, AMICULUM’s Shweta Avasthi and Abigail Montgomery will be attending the International AIDS Society #AIDS2024 Conference in Munich, Germany! We’re looking forward to great discussions about advancements in HIV/AIDS treatment and prevention and the opportunity to connect with Global thought leaders. If you’ll be there let us know, it would be great to meet up! #HIV #Munich
-
Last week, many of our team members enjoyed getting together and celebrating in-person for our annual event across our global locations. Here are a few photo highlights! #annualevent24
-
And that's a wrap on AMICULUM's Learning at Work Week! Thank you to all our speakers, facilitators, guests and attendees for the series of inspiring and thought-provoking sessions that made this event such a success. It was a great opportunity to connect across locations and support our continuous learning culture. Thank you to everyone who made this week possible!
-
We had a great day yesterday bringing together colleagues around the world for our business update. Members our our leadership team presented from 5 locations around the UK including our London contingent in Marble Arch
Who do head mics make you think of? Madonna? Britney Spears? Dua Lipa? Whoever it is, we had a great time yesterday doing our best impression of pop stars (without the singing or dancing thank goodness!) at the London hub of the AMICULUM annual event. It was brilliant to see everyone at Marble Arch in real life, and to connect with our colleagues in hubs across the UK, Asia and US to talk about our vision for the future and all the great stuff that's already happening to make that a reality.
-
Today at AMICULUM's Learning at Work Week, we will dive into the realms of AI and innovation with Stephen Wilson and Andrew Dobb before getting creative with experiments in generative AI.
-
Today at AMICULUM's Learning at Work Week, Georgia Hollier-Hann will be discussing the relationship between market access and other pharma functions with a host of AMICULUM colleagues. Then Kirsty Okyne will be joined by a special guest as they discuss the importance of diversity, equity and inclusion in clinical trials.
-
Today marks the start of AMICULUM's Learning at Work Week. Our colleagues will come together to focus their thoughts and pursue growth and empowerment through a series of live sessions and activities. To kick start the week, we will be hearing from Laura Dickinson, Jane Veart and our team of Mental Health First Aiders followed by Zoë van Helmond and Jennifer Cheung's enterprising activities.